Articles From: Danish Deputy Prime Minister and Minister of Finance to Ring the Nasdaq Stock Market Closing Bell to Data Suggest Swiss SNB Bought Around $65 Billion in Forex in January


2015/1/15
ADVISORY, Jan.
Sign-up for Danish Deputy Prime Minister and Minister of Finance to Ring the Nasdaq Stock Market Closing Bell investment picks
2015/2/10
By Anna Molin Lenders in Denmark are taking unprecedented steps to recoup expenses incurred from the negative interest rates that have followed the Danish central bank's policy of defending its currency cap against the euro.
Sign-up for Danish Lenders Take Unprecedented Steps to Combat Negative Interest Rates investment picks
2015/2/20
By Ruth Bender PARIS-- Danone SA on Friday said it expects its profit margin to grow slightly this year after several years of declines as the French dairy maker starts to see an improvement in its key fresh dairy business in Europe.
Sign-up for Danone Forecasts Profit Margin Growth investment picks
2015/2/3
By Anna Molin Denmark's biggest lender Danske Bank A/S (DANSKE.KO) Tuesday hiked its dividend for the full year and said its strong capital position would allow it to launch a share buy-back program in 2015, despite swinging to a fourth quarter net loss following a hefty goodwill writedown.
Sign-up for Danske Bank Swings To 4Q Net Loss On Goodwill Writedown investment picks
2015/2/5
CHONGQING, China , Feb.
Sign-up for Daqo New Energy Corp. Announces Pricing of Registered Follow-on Offering of American Depositary Shares investment picks
2014/12/30
CHONGQING, China , Dec.
Sign-up for Daqo New Energy Corp. Announces Resolution Adopted at 2014 Annual General Meeting investment picks
2015/1/6
http://www.marketwire.com/library/MwGo/2015/1/5/11G029613/Logo1-1000450577.jpg RALEIGH, NC--(Marketwired - January 06, 2015) - DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that it has been granted a "barrier-to-innovation" waiver for certain product and establishment fees.
Sign-up for DARA BioSciences Granted Waiver of Product and Establishment Fees by the FDA investment picks
2015/2/4
McDermott International, Inc. (NYSE: MDR) (“McDermott”) announced today that Darcey Matthews has joined McDermott as Vice President, Investor Relations, effective 2 February 2015.
Sign-up for Darcey Matthews Joins McDermott as Vice President, Investor Relations investment picks
2015/2/23
Gene Lee Appointed CEO by Unanimous Vote of Board Gene Lee Has Been Operating as Interim CEO Brings 30-Plus Years of Restaurant Operating Experience Gene Lee Appointed to Darden's Board of Directors ORLANDO, Fla.
Sign-up for Darden Announces Appointment Of Chief Executive Officer investment picks
2015/2/23
By Chelsey Dulaney Lee has been serving as interim chief of Olive Garden parent Darden Restaurants Inc. on Monday said it named Eugene "Gene" Lee Jr.
Sign-up for Darden Restaurants names Gene Lee CEO investment picks
2014/12/8
ORLANDO, Fla.
Sign-up for Darden Restaurants To Host Its FY15 Second Quarter Conference Call on the Internet investment picks
2014/12/16
Darden Restaurants' stock (DRI) rose 1.3% in after-hours trade Tuesday, after the casual-dining restaurant chain reported better-than-expected fiscal second-quarter profit and sales.
Sign-up for Darden Restaurants' stock rises after beating profit, sales expectations investment picks
2015/2/9
ORLANDO, Fla.
Sign-up for Darden Sets Date For FY15 Third Quarter Earnings Release And Conference Call investment picks
2014/12/8
Company Names John O.
Sign-up for Darling Ingredients Inc. Announces Appointment Of New Chief Financial Officer investment picks
2015/2/27
IRVING, Texas , Feb.
Sign-up for Darling Ingredients Inc. Announces Fourth Quarter And Fiscal Year End 2014 Earnings Conference Call And Webcast investment picks
2015/2/27
Company Names Justinus J.G.M. Sanders as Director IRVING, Texas , Feb.
Sign-up for Darling Ingredients Inc. Announces New Appointment To Board Of Directors investment picks
2014/12/26
IRVING, Texas , Dec.
Sign-up for Darling Ingredients Inc. To Benefit From Biodiesel Tax Credit investment picks
2015/1/20
Who doesn’t enjoy everything that comes with a “spa day”? Now you can experience a little taste of it on the go with DASANI DROPS Infusions- a new easy way to enhance your water with a splash of flavor to leave you refreshed.
Sign-up for DASANI® Presents DASANI DROPS® Infusions investment picks
2014/12/8
95% (19/20) Overall Response Rate (ORR) in Patients with High-Risk CLL, the patient population to be studied in recently announced Phase 3 Clinical Trial being conducted under Special Protocol Assessment (SPA) 87% (34/39) ORR per iwCLL criteria in all evaluable CLL patients plus an additional 10% of patients with a nodal PR or nodal reductions ranging from 20%-45% without disease progression 88% (7/8) ORR in all evaluable Mantle Cell Lymphoma (MCL) patients with a 38% (3/8) Complete Response rate Combination of TG-1101 + Ibrutinib well tolerated with limited Grade 3/4 events reported to date SAN FRANCISCO, Dec.
Sign-up for Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL) investment picks
2015/2/27
DATA Group Ltd.
Sign-up for DATA Group Ltd. - Fourth Quarter 2014 Earnings Results Conference Call investment picks
2015/2/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1175097&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Corporation to Announce Fourth Quarter and 2014 Financial Results on February 26, 2015 investment picks
2014/12/1
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162170&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Engages SM Berger & Company as Investor Relations Firm investment picks
2015/2/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1178056&ProfileId=051205&sourceType=1 REDMOND, WA --
Sign-up for Data I/O Reports 2014 Fourth Quarter Results investment picks
2014/12/10
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today early study findings demonstrating an overall response rate of 18.5 percent with KEYTRUDA, the company’s anti-PD-1 therapy, as assessed by RECIST v1.1, central review (n=5/27), in PD-L1 positive, advanced triple-negative breast cancer – one of the most aggressive forms of breast cancer.
Sign-up for Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium investment picks
2014/12/6
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today early study findings demonstrating that KEYTRUDA ® (pembrolizumab), the company’s anti-PD-1 therapy, achieved an overall response rate of 66 percent, as assessed by International Harmonization Project response criteria (n=19/29: 95% CI, 46-82), in transplant-ineligible and failure patients with relapsed/refractory classical Hodgkin Lymphoma (cHL) whose disease progressed on or after treatment with brentuximab vedotin.
Sign-up for Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting investment picks
2014/12/12
http://media.marketwire.com/attachments/201203/41309_medivation_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164742&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA and TOKYO, JAPAN --
Sign-up for Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer investment picks
2015/1/26
By David Benoit In the hedge-fund world, there is no more closely guarded secret than what stock a firm is preparing to target.
Sign-up for Data providers tell banks, brokers what reports subscribers read investment picks
2015/2/6
ZURICH--New data published on Friday by the Swiss National Bank suggest it bought around 60 billion Swiss francs (around $65 billion) worth of foreign currencies last month to blunt the surge in the Swiss franc's value, even after the central bank removed a strict cap on the currency halfway through January, according to analysts.
Sign-up for Data Suggest SNB Bought Around $65 Billion in Forex in January investment picks
2015/2/6
By Neil MacLucas ZURICH--New data published on Friday by the Swiss National Bank suggest it bought around 60 billion Swiss francs (around $65 billion) worth of foreign currencies last month to blunt the surge in the Swiss franc's value, even after the central bank removed a strict cap on the currency halfway through January, according to analysts.
Sign-up for Data Suggest Swiss SNB Bought Around $65 Billion in Forex in January investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Danish Deputy Prime Minister and Minister of Finance to Ring the Nasdaq Stock Market Closing Bell to Data Suggest Swiss SNB Bought Around $65 Billion in Forex in January
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent